Acquisition and Long-term Observation of Patients With Severe Allergic Reactions

NCT05210543 · tracked via the Priya Life Science Germany tracker

Sponsor

Charite University, Berlin, Germany

Phase

Observational

Started

2007-01-01

Last updated

2024-08-21

Condition(s) studied

Anaphylaxis

Investigational drug(s) / intervention(s)

not applicable, observational study

not applicable, observational study: Patients do not receive intervention; observational study

Study summary

The Anaphylaxis Registry aims to assess data in a standardized form about symptoms, triggers, cofactors and therapy management from patients who experienced an anaphylactic reaction. This should improve diagnosis and long-term management of these life-threatening allergic reactions.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Anaphylactic reaction within the past 12 months Exclusion Criteria: \-

Primary outcome measure(s)

Influence of risk factors — 10 years
Correlation between risk factors (age, epiphenomenon, comorbidity) and severity of anaphylaxis

Trial sites (1)

Facility	City	Region	Status
Charité - Universitätsmedizin Berlin	Berlin	Germany	Recruiting

More Charite University, Berlin, Germany trials in Germany

Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE) Starting soon

Berlin-Brandenburg Pregnancy Cohort Recruiting

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture Recruiting

Quality Contract: Prevention of Postoperative Delirium in the Care of Older Patients (QV-POD-2) Recruiting

Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05210543 on ClinicalTrials.gov ↗ ← All trials in Germany